Owens & Minor Q1 EPS Estimate Lowered by Leerink Partnrs

Owens & Minor, Inc. (NYSE:OMI) – Equities research analysts at Leerink Partnrs lowered their Q1 2025 earnings per share (EPS) estimates for Owens & Minor in a research note issued to investors on Monday, February 3rd. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings of $0.28 per share for the quarter, down from their prior forecast of $0.29. The consensus estimate for Owens & Minor’s current full-year earnings is $1.49 per share. Leerink Partnrs also issued estimates for Owens & Minor’s Q2 2025 earnings at $0.39 EPS, Q3 2025 earnings at $0.43 EPS, Q4 2025 earnings at $0.48 EPS, FY2025 earnings at $1.58 EPS, FY2026 earnings at $1.97 EPS and FY2027 earnings at $2.36 EPS.

Owens & Minor (NYSE:OMI) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. The firm had revenue of $2.72 billion for the quarter, compared to analysts’ expectations of $2.68 billion. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. Owens & Minor’s revenue was up 5.0% on a year-over-year basis. During the same quarter last year, the business posted $0.44 EPS.

OMI has been the topic of a number of other research reports. Robert W. Baird dropped their price target on Owens & Minor from $15.00 to $14.00 and set a “neutral” rating on the stock in a research note on Tuesday. Barclays lowered their target price on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 5th. Citigroup lowered their target price on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Finally, UBS Group lowered their target price on Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Owens & Minor currently has a consensus rating of “Hold” and an average price target of $18.50.

Owens & Minor Trading Down 2.9 %

Shares of OMI opened at $8.64 on Wednesday. The business’s 50-day moving average price is $13.51 and its 200 day moving average price is $14.17. The stock has a market capitalization of $666.08 million, a P/E ratio of -13.29, a P/E/G ratio of 0.40 and a beta of 0.48. Owens & Minor has a 1-year low of $8.57 and a 1-year high of $28.35. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11.

Institutional Investors Weigh In On Owens & Minor

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Quarry LP lifted its holdings in shares of Owens & Minor by 290.1% during the second quarter. Quarry LP now owns 2,099 shares of the company’s stock worth $28,000 after buying an additional 1,561 shares during the last quarter. Blue Trust Inc. lifted its holdings in shares of Owens & Minor by 176.8% during the third quarter. Blue Trust Inc. now owns 2,787 shares of the company’s stock worth $44,000 after buying an additional 1,780 shares during the last quarter. KBC Group NV lifted its holdings in shares of Owens & Minor by 98.2% during the fourth quarter. KBC Group NV now owns 4,434 shares of the company’s stock worth $58,000 after buying an additional 2,197 shares during the last quarter. Meeder Asset Management Inc. lifted its holdings in shares of Owens & Minor by 844.1% during the third quarter. Meeder Asset Management Inc. now owns 9,016 shares of the company’s stock worth $141,000 after buying an additional 8,061 shares during the last quarter. Finally, Marshall Wace LLP lifted its holdings in shares of Owens & Minor by 38.4% during the second quarter. Marshall Wace LLP now owns 11,100 shares of the company’s stock worth $150,000 after buying an additional 3,077 shares during the last quarter. 98.04% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CFO Jonathan A. Leon sold 5,282 shares of the business’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the sale, the chief financial officer now directly owns 130,822 shares in the company, valued at approximately $1,546,316.04. The trade was a 3.88 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 2.62% of the stock is owned by corporate insiders.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.